Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  Detox-B adjuvant
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-11 of 11 for your search:
Start Over
Phase III Multicenter, Randomized, Controlled Study of THERATOPE Vaccine in Women With Metastatic Breast Cancer (Summary Last Modified 05/2001)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BIOMIRA-STn-BR-104, NCI-V98-1489, NCT00003638
Phase III Randomized Study of Melacine (Melanoma Cell Lysate Vaccine) vs Chemotherapy with DTIC/CDDP/BCNU/TMX in Patients with Disseminated Melanoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: RIR-91CO28-CC, NCI-V92-0019, NCI-V92-0102
Phase II Pilot Adjuvant Study of Vaccination with Sialyl Tn Antigen Covalenty Attached to KLH plus Detox in Patients with High-Risk Resected Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor:
Protocol IDs: MSKCC-91095, NCI-V91-0167
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000063475, NCI-94-C-0096D, NCI-T93-0152N, T93-0152, NCT00019006
Phase I Study of IL-2/CTX and Autologous Tumor Cell Vaccines in the Treatment of Metastatic Renal Carcinoma and Melanoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: URCC-3788M, NCI-T88-0151D, T88-0151
Phase I Study of Adjuvant IL-1A Immunotherapy with an Allogeneic Colon Cancer Vaccine for Dukes' D Colon or Rectal Cancer (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 to 100
Sponsor: NCI
Protocol IDs: URCC-4290M, NCI-T91-0094D, T91-0094
Start Over